Global Oxycodone Hydrochloride Extended-Release Drug Market Growth 2026-2032

April 2026 | 105 pages | ID: G9E24A199852EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Oxycodone Hydrochloride Extended-Release Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the ?Oxycodone Hydrochloride Extended-Release Drug Industry Forecast? looks at past sales and reviews total world Oxycodone Hydrochloride Extended-Release Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Oxycodone Hydrochloride Extended-Release Drug sales for 2026 through 2032. With Oxycodone Hydrochloride Extended-Release Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oxycodone Hydrochloride Extended-Release Drug industry.

This Insight Report provides a comprehensive analysis of the global Oxycodone Hydrochloride Extended-Release Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oxycodone Hydrochloride Extended-Release Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oxycodone Hydrochloride Extended-Release Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oxycodone Hydrochloride Extended-Release Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oxycodone Hydrochloride Extended-Release Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Oxycodone Hydrochloride Extended-Release Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Extended-Release Tablets
  • Extended-Release Capsules
Segmentation by Application:
  • Hospital
  • Clinic
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • PURDUE PHARMA LP
  • Teva Pharmaceutical Industries Ltd
  • Epic Pharma, LLC
  • Mylan
  • Amneal Pharmaceuticals, Inc.?Impax?
  • Lifeon Pharmaceutical
  • Humanwell Healthcare
  • Mallinckrodt Pharmaceuticals
  • Pfizer
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Oxycodone Hydrochloride Extended-Release Drug market?
  • What factors are driving Oxycodone Hydrochloride Extended-Release Drug market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Oxycodone Hydrochloride Extended-Release Drug market opportunities vary by end market size?
  • How does Oxycodone Hydrochloride Extended-Release Drug break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Oxycodone Hydrochloride Extended-Release Drug by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Oxycodone Hydrochloride Extended-Release Drug by Country/Region, 2021, 2025 & 2032
2.2 Oxycodone Hydrochloride Extended-Release Drug Segment by Type
  2.2.1 Extended-Release Tablets
  2.2.2 Extended-Release Capsules
  2.2.3 Oxycodone Hydrochloride Extended-Release Drug Sales by Type
    2.2.3.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Type (2021-2026)
2.3 Oxycodone Hydrochloride Extended-Release Drug Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Oxycodone Hydrochloride Extended-Release Drug Sales by Application
    2.3.3.1 Global Oxycodone Hydrochloride Extended-Release Drug Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Oxycodone Hydrochloride Extended-Release Drug Breakdown Data by Company
  3.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Annual Sales by Company (2021-2026)
  3.1.2 Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Company (2021-2026)
3.2 Global Oxycodone Hydrochloride Extended-Release Drug Annual Revenue by Company (2021-2026)
  3.2.1 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Company (2021-2026)
  3.2.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Company (2021-2026)
3.3 Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Company
3.4 Key Manufacturers Oxycodone Hydrochloride Extended-Release Drug Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Oxycodone Hydrochloride Extended-Release Drug Product Location Distribution
  3.4.2 Players Oxycodone Hydrochloride Extended-Release Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE DRUG BY GEOGRAPHIC REGION

4.1 World Historic Oxycodone Hydrochloride Extended-Release Drug Market Size by Geographic Region (2021-2026)
  4.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Oxycodone Hydrochloride Extended-Release Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oxycodone Hydrochloride Extended-Release Drug Market Size by Country/Region (2021-2026)
  4.2.1 Global Oxycodone Hydrochloride Extended-Release Drug Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Oxycodone Hydrochloride Extended-Release Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oxycodone Hydrochloride Extended-Release Drug Sales Growth
4.4 APAC Oxycodone Hydrochloride Extended-Release Drug Sales Growth
4.5 Europe Oxycodone Hydrochloride Extended-Release Drug Sales Growth
4.6 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Growth

5 AMERICAS

5.1 Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Country
  5.1.1 Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2021-2026)
  5.1.2 Americas Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2021-2026)
5.2 Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2021-2026)
5.3 Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Region
  6.1.1 APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2021-2026)
  6.1.2 APAC Oxycodone Hydrochloride Extended-Release Drug Revenue by Region (2021-2026)
6.2 APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2021-2026)
6.3 APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Oxycodone Hydrochloride Extended-Release Drug by Country
  7.1.1 Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2021-2026)
  7.1.2 Europe Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2021-2026)
7.2 Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2021-2026)
7.3 Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug by Country
  8.1.1 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oxycodone Hydrochloride Extended-Release Drug
10.3 Manufacturing Process Analysis of Oxycodone Hydrochloride Extended-Release Drug
10.4 Industry Chain Structure of Oxycodone Hydrochloride Extended-Release Drug

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Oxycodone Hydrochloride Extended-Release Drug Distributors
11.3 Oxycodone Hydrochloride Extended-Release Drug Customer

12 WORLD FORECAST REVIEW FOR OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE DRUG BY GEOGRAPHIC REGION

12.1 Global Oxycodone Hydrochloride Extended-Release Drug Market Size Forecast by Region
  12.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Forecast by Region (2027-2032)
  12.1.2 Global Oxycodone Hydrochloride Extended-Release Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oxycodone Hydrochloride Extended-Release Drug Forecast by Type (2027-2032)
12.7 Global Oxycodone Hydrochloride Extended-Release Drug Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 PURDUE PHARMA LP
  13.1.1 PURDUE PHARMA LP Company Information
  13.1.2 PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
  13.1.3 PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 PURDUE PHARMA LP Main Business Overview
  13.1.5 PURDUE PHARMA LP Latest Developments
13.2 Teva Pharmaceutical Industries Ltd
  13.2.1 Teva Pharmaceutical Industries Ltd Company Information
  13.2.2 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
  13.2.3 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Teva Pharmaceutical Industries Ltd Main Business Overview
  13.2.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.3 Epic Pharma, LLC
  13.3.1 Epic Pharma, LLC Company Information
  13.3.2 Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
  13.3.3 Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Epic Pharma, LLC Main Business Overview
  13.3.5 Epic Pharma, LLC Latest Developments
13.4 Mylan
  13.4.1 Mylan Company Information
  13.4.2 Mylan Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
  13.4.3 Mylan Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Mylan Main Business Overview
  13.4.5 Mylan Latest Developments
13.5 Amneal Pharmaceuticals, Inc.?Impax?
  13.5.1 Amneal Pharmaceuticals, Inc.?Impax? Company Information
  13.5.2 Amneal Pharmaceuticals, Inc.?Impax? Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
  13.5.3 Amneal Pharmaceuticals, Inc.?Impax? Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Amneal Pharmaceuticals, Inc.?Impax? Main Business Overview
  13.5.5 Amneal Pharmaceuticals, Inc.?Impax? Latest Developments
13.6 Lifeon Pharmaceutical
  13.6.1 Lifeon Pharmaceutical Company Information
  13.6.2 Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
  13.6.3 Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Lifeon Pharmaceutical Main Business Overview
  13.6.5 Lifeon Pharmaceutical Latest Developments
13.7 Humanwell Healthcare
  13.7.1 Humanwell Healthcare Company Information
  13.7.2 Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
  13.7.3 Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Humanwell Healthcare Main Business Overview
  13.7.5 Humanwell Healthcare Latest Developments
13.8 Mallinckrodt Pharmaceuticals
  13.8.1 Mallinckrodt Pharmaceuticals Company Information
  13.8.2 Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
  13.8.3 Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Mallinckrodt Pharmaceuticals Main Business Overview
  13.8.5 Mallinckrodt Pharmaceuticals Latest Developments
13.9 Pfizer
  13.9.1 Pfizer Company Information
  13.9.2 Pfizer Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
  13.9.3 Pfizer Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Pfizer Main Business Overview
  13.9.5 Pfizer Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Oxycodone Hydrochloride Extended-Release Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oxycodone Hydrochloride Extended-Release Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Extended-ReleaseTablets
Table 4. Major Players of Extended-Release Capsules
Table 5. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2021-2026)
Table 7. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Type (2021-2026)
Table 9. Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Oxycodone Hydrochloride Extended-Release Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global Oxycodone Hydrochloride Extended-Release Drug Sale Market Share by Application (2021-2026)
Table 12. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Application (2021-2026)
Table 14. Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Company (2021-2026)
Table 17. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Company (2021-2026)
Table 19. Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Oxycodone Hydrochloride Extended-Release Drug Producing Area Distribution and Sales Area
Table 21. Players Oxycodone Hydrochloride Extended-Release Drug Products Offered
Table 22. Oxycodone Hydrochloride Extended-Release Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country (2021-2026)
Table 35. Americas Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Region (2021-2026)
Table 40. APAC Oxycodone Hydrochloride Extended-Release Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Oxycodone Hydrochloride Extended-Release Drug
Table 52. Key Market Challenges & Risks of Oxycodone Hydrochloride Extended-Release Drug
Table 53. Key Industry Trends of Oxycodone Hydrochloride Extended-Release Drug
Table 54. Oxycodone Hydrochloride Extended-Release Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oxycodone Hydrochloride Extended-Release Drug Distributors List
Table 57. Oxycodone Hydrochloride Extended-Release Drug Customer List
Table 58. Global Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Oxycodone Hydrochloride Extended-Release Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Oxycodone Hydrochloride Extended-Release Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. PURDUE PHARMA LP Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 74. PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. PURDUE PHARMA LP Main Business
Table 76. PURDUE PHARMA LP Latest Developments
Table 77. Teva Pharmaceutical Industries Ltd Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 79. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Teva Pharmaceutical Industries Ltd Main Business
Table 81. Teva Pharmaceutical Industries Ltd Latest Developments
Table 82. Epic Pharma, LLC Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 84. Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Epic Pharma, LLC Main Business
Table 86. Epic Pharma, LLC Latest Developments
Table 87. Mylan Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Mylan Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 89. Mylan Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Mylan Main Business
Table 91. Mylan Latest Developments
Table 92. Amneal Pharmaceuticals, Inc.?Impax? Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Amneal Pharmaceuticals, Inc.?Impax? Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 94. Amneal Pharmaceuticals, Inc.?Impax? Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Amneal Pharmaceuticals, Inc.?Impax? Main Business
Table 96. Amneal Pharmaceuticals, Inc.?Impax? Latest Developments
Table 97. Lifeon Pharmaceutical Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 99. Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Lifeon Pharmaceutical Main Business
Table 101. Lifeon Pharmaceutical Latest Developments
Table 102. Humanwell Healthcare Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 104. Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Humanwell Healthcare Main Business
Table 106. Humanwell Healthcare Latest Developments
Table 107. Mallinckrodt Pharmaceuticals Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 109. Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Mallinckrodt Pharmaceuticals Main Business
Table 111. Mallinckrodt Pharmaceuticals Latest Developments
Table 112. Pfizer Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 114. Pfizer Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments

LIST OF FIGURES

Figure 1. Picture of Oxycodone Hydrochloride Extended-Release Drug
Figure 2. Oxycodone Hydrochloride Extended-Release Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oxycodone Hydrochloride Extended-Release Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oxycodone Hydrochloride Extended-Release Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country/Region (2025)
Figure 10. Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Extended-ReleaseTablets
Figure 12. Product Picture of Extended-Release Capsules
Figure 13. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type in 2026
Figure 14. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Type (2021-2026)
Figure 15. Oxycodone Hydrochloride Extended-Release Drug Consumed in Hospital
Figure 16. Global Oxycodone Hydrochloride Extended-Release Drug Market: Hospital (2021-2026) & (K Units)
Figure 17. Oxycodone Hydrochloride Extended-Release Drug Consumed in Clinic
Figure 18. Global Oxycodone Hydrochloride Extended-Release Drug Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Oxycodone Hydrochloride Extended-Release Drug Sale Market Share by Application (2025)
Figure 20. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Application in 2026
Figure 21. Oxycodone Hydrochloride Extended-Release Drug Sales by Company in 2026 (K Units)
Figure 22. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Company in 2026
Figure 23. Oxycodone Hydrochloride Extended-Release Drug Revenue by Company in 2026 ($ millions)
Figure 24. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Company in 2026
Figure 25. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Oxycodone Hydrochloride Extended-Release Drug Sales 2021-2026 (K Units)
Figure 28. Americas Oxycodone Hydrochloride Extended-Release Drug Revenue 2021-2026 ($ millions)
Figure 29. APAC Oxycodone Hydrochloride Extended-Release Drug Sales 2021-2026 (K Units)
Figure 30. APAC Oxycodone Hydrochloride Extended-Release Drug Revenue 2021-2026 ($ millions)
Figure 31. Europe Oxycodone Hydrochloride Extended-Release Drug Sales 2021-2026 (K Units)
Figure 32. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue 2021-2026 ($ millions)
Figure 35. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country in 2026
Figure 36. Americas Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2021-2026)
Figure 37. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2021-2026)
Figure 38. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2021-2026)
Figure 39. United States Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Region in 2026
Figure 44. APAC Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Region (2021-2026)
Figure 45. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2021-2026)
Figure 46. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2021-2026)
Figure 47. China Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. India Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country in 2026
Figure 55. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2021-2026)
Figure 56. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2021-2026)
Figure 57. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2021-2026)
Figure 58. Germany Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. France Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2021-2026)
Figure 66. Egypt Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Oxycodone Hydrochloride Extended-Release Drug in 2026
Figure 72. Manufacturing Process Analysis of Oxycodone Hydrochloride Extended-Release Drug
Figure 73. Industry Chain Structure of Oxycodone Hydrochloride Extended-Release Drug
Figure 74. Channels of Distribution
Figure 75. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Forecast by Region (2027-2032)
Figure 76. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share Forecast by Application (2027-2032)


More Publications